1,600,000 Shares* Boston Biomedica, Inc. Common Stock UNDERWRITING AGREEMENTBoston Biomedica Inc • October 25th, 1996 • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.8 LEASEBoston Biomedica Inc • October 25th, 1996 • In vitro & in vivo diagnostic substances • Connecticut
RECITALSVoting Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Delaware
Names of Subscribers: Richard P. Kiphart Andrew Gluck David Valentine Rebecca Kiphart Arthur Hill SUBSCRIPTION AGREEMENT Boston Biomedica, Inc. 375 West Street West Bridgewater, Massachusetts 02379 December 6, 2001 Gentlemen:Subscription Agreement • April 1st, 2002 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
The undersigned persons (collectively, the “Investors”), by executing this Subscription Agreement, hereby subscribe for the number of shares of Common Stock, $0.01 par value per share (the “Common Stock”), of Boston Biomedica, Inc., a Massachusetts corporation (the “Company”) set forth in paragraph 2 and agree to be bound by the terms and conditions hereof.
DATED AS OF AUGUST 25, 2000 BY AND BETWEENSecurities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4.9Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 8th, 2001 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • California
Exhibit 1 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.4 STANDARD FORM 26 (REV. 4-85) NSN 7540-01-152-8069 OMB No. 0990-0115 RFP 95-3 AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER UNDER DPAS (15 CFR 350) RATING PAGE 1 OF PAGES 21 2. CONTRACT (Proc. inst. ident.) No. NO1-AI-55277 3. EFFECTIVE...Master Agreement • October 25th, 1996 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
Exhibit 10.34 LOAN AGREEMENT AGREEMENT entered into this 31st day of March, 2000 by and between Boston Biomedica, Inc., a corporation organized pursuant to the laws of the Commonwealth of Massachusetts with a principal place of business at 375 West...Loan Agreement • March 31st, 2003 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
7.NAME AND ADDRESS OF THE CONTRACTOR 8. DELIVERY (No., street, city, county, State [ ]FOB OTHER [X]FOB DESTINATION and ZIP Code) -------------------------------------- BTRL CONTRACTS & SER., INC. 9. DISCOUNT FOR PROMPT PAYMENT DBA/BIOTECH RES. LAB. 3...Boston Biomedica Inc • May 15th, 1997 • In vitro & in vivo diagnostic substances
Exhibit 4.10Registration Rights Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
EXHIBIT 10.20 PREFERRED STOCK PURCHASE AGREEMENT 1150 SHARES OF PREFERRED STOCK OF BIOSEQ, INC. Dated: as of October 7, 1996 PREFERRED STOCK PURCHASE AGREEMENT ---------------------------------- TABLE OF CONTENTS ----------------- PARTIES RECITALSPreferred Stock Purchase Agreement • October 8th, 1996 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4.2Securities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4 AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • April 16th, 2004 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
WITNESSETHLicense Agreement • March 30th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC. WARRANT NO. F-__Common Stock Purchase Warrant • November 10th, 2011 • Pressure Biosciences Inc • Measuring & controlling devices, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May ___, 2012 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock of the Company, par value $0.01 per share (the “Common Stock”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 4.4Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances • Massachusetts
10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTEPressure Biosciences Inc • December 30th, 2019 • Laboratory analytical instruments • New York
THIS 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued by Pressure BioSciences, Inc., a Massachusetts corporation, (the “Company”), designated as its 10% Senior Secured Convertible Promissory Note due 2020 (this note, the “Note” and, collectively with any other notes of such series, the “Notes”). The Notes are secured by a General Security Agreement between the Company and the Holder, dated of even date herewith.
EXHIBIT 10.21 NEITHER THIS WARRANT NOR THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR STATE SECURITIES LAWS. NO SALE, TRANSFER OR OTHER DISPOSITION OF THIS WARRANT OR SAID SHARES...Boston Biomedica Inc • October 8th, 1996 • In vitro & in vivo diagnostic substances • Massachusetts
TNL6-99 THIS LEASE, Made this 30th day of September, 1999, by and between MIE Properties, Inc., as agent for owner, herein called "Landlord", and BBI BIOTECH RESEARCH LABORATORIES, INC., herein called "Tenant". WITNESSETH, that in consideration of the...Lease • March 30th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 10th, 2011 • Pressure Biosciences Inc • Measuring & controlling devices, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 8, 2011, between Pressure Biosciences, Inc., a Massachusetts corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AGREEMENTAgreement • October 25th, 1996 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Maryland
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 16th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March ___, 2017, between Pressure BioSciences, Inc. a Massachusetts corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
ContractPressure Biosciences Inc • April 24th, 2017 • Laboratory analytical instruments • New York
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES, UNLESS OTHERWISE PROHIBITED BY FEDERAL OR STATE SECURITIE
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC. Warrant No.Pressure Biosciences Inc • November 15th, 2016 • Laboratory analytical instruments • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
DATED AS OFSecurities Purchase Agreement • September 8th, 2000 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
EXHIBIT 10.22 STOCKHOLDERS' AGREEMENT STOCKHOLDERS' AGREEMENT, made as of October 7, 1996 (the "Agreement") by and among Bioseq, Inc., a Massachusetts corporation with a principal office at 25 Olympia Avenue, Unit F, Woburn, Massachusetts 01801 (the...Stockholders' Agreement • October 8th, 1996 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2019 • Pressure Biosciences Inc • Laboratory analytical instruments • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of the date listed on the signature pages hereto, is by and among Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
WARRANT PURCHASE AGREEMENT Warrants to Purchase 500,000 Shares of the Common Stock of Boston Biomedica, Inc. Dated: August 18, 1999 WARRANT PURCHASE AGREEMENT -------------------------- TABLE OF CONTENTS ----------------- ARTICLE 1. DESCRIPTION OF...Warrant Purchase Agreement • November 15th, 1999 • Boston Biomedica Inc • In vitro & in vivo diagnostic substances • Massachusetts
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC.Pressure Biosciences Inc • April 5th, 2022 • Laboratory analytical instruments • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, XXXXXXXXX or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after XXXXXXXXX (the “Initial Exercise Date”) and on or prior to the close of business on the X-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to XXXXXX shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 4.8Boston Biomedica Inc • September 8th, 2000 • In vitro & in vivo diagnostic substances • Massachusetts
UNDERWRITING AGREEMENT Between PRESSURE BIOSCIENCES, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters PRESSURE BIOSCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York
The undersigned, Pressure BioSciences, Inc., a corporation formed under the laws of the Commonwealth of Massachusetts (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Pressure BioSciences, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Joseph Gunnar & Co., LLC. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
WARRANT AGENT AGREEMENTWarrant Agent Agreement • August 10th, 2017 • Pressure Biosciences Inc • Laboratory analytical instruments • New York
WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of _________, 2017 (the “Issuance Date”) between Pressure BioSciences, Inc., a company incorporated under the laws of the Commonwealth of Massachusetts (the “Company”), and Computershare Trust Company, N.A. (the “Warrant Agent”).
PLACEMENT AGENCY AGREEMENT April 6, 2012Placement Agency Agreement • April 9th, 2012 • Pressure Biosciences Inc • Measuring & controlling devices, nec • New York
